Mainland Chinese head to Hong Kong for mRNA COVID-19 vaccines

  • 📰 gmanews
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Scores of mainland Chinese travelers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections which have overwhelmed its health system.

A private hospital in the special Chinese administrative region of Hong Kong welcomed the first batch of mainland customers on Thursday, just five days after China reopened its borders for the first time in three years, allowing quarantine free travel.

Liang had received three domestically developed vaccine doses from China's Sinovac over the past two years but said she took Pfizer-BioNtech's bivalent booster vaccine to better protect herself against the virus. Virtus, which has received more than 300 inquiries so far about the vaccines, is expecting more mainland customers to come to Hong Kong in the coming weeks and months, the company's chief medical officer Samuel Kwok told reporters.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

‘Not necessary’ to dwell on COVID-19 death tally, Chinese experts sayChinese health officials said Wednesday it was "not necessary" to dwell on the exact number of COVID-19 deaths in the country, days after the World Health Organization criticized authorities&39; accounting of a surge in cases there. Not necessary para hindi alam ng mga tao na sobrang dami na ang namatay?
Source: gmanews - 🏆 11. / 68 Read more »